Contactless Optical Monitoring of AV Access Using the PatenSee System in Outpatient Hemodialysis Patients (NCT07194395)
A Prospective International Multicenter, Non-Interventional, Single Arm, Blinded Feasibility Study to Assess the Contactless Optical Monitoring of AV Access Using the PatenSee System in Dialysis Patients
🩺 Plain-English Summary (8th-Grade Level)
This is a prospective, non-interventional, single arm, international multicenter study in which up to 120 adult participants with kidney failure requiring regular hemodialysis through arteriovenous (AV) access (AV fistula or graft) will be recruited and evaluated using the PatenSee system. Data captured on the PatenSee system will be analyzed and evaluated against standard of care clinical monitoring of AV accesses.
Who can join: Review the eligibility criteria below.
Location: Henry Ford Hospital — Detroit, Michigan
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Henry Ford Hospital — Detroit, Michigan
- Meir Medical Center — Kfar Saba, Hasharon
📞 Contact the Study Coordinator
Phone: 972-508341678
Email: Naama.b@patensee.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Hemodialysis
- Dialysis Less Frequently in the Elderly — Vancouver, British Columbia
- Assessment of a Wearable Ultrafiltration Device — London, Ontario
- Study to Evaluate the Effects of AV-001 on HD-induced Brain Injury. — London, Ontario
- Exercise Preconditioning to Protect Against Dialysis-induced Cardiac Injury — London, Ontario
- Physical Activity Prescription Program for Hemodialysis Patients — Tucson, Arizona
- Alirocumab in Patients on a Stable Dialysis Regimen — Dallas, Texas
Explore by condition: All Hemodialysis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.